Analyze Diet
Equine veterinary journal2020; 53(1); 30-37; doi: 10.1111/evj.13290

Genetics of equine bleeding disorders.

Abstract: Genetic bleeding disorders can have a profound impact on a horse's health and athletic career. As such, it is important to understand the mechanisms of these diseases and how they are diagnosed. These diseases include haemophilia A, von Willebrand disease, prekallikrein deficiency, Glanzmann's Thrombasthenia and Atypical Equine Thrombasthenia. Exercise-induced pulmonary haemorrhage also has a proposed genetic component. Genetic mutations have been identified for haemophilia A and Glanzmann's Thrombasthenia in the horse. Mutations are known for von Willebrand disease and prekallikrein deficiency in other species. In the absence of genetic tests, bleeding disorders are typically diagnosed by measuring platelet function, von Willebrand factor, and other coagulation protein levels and activities. For autosomal recessive diseases, genetic testing can prevent the breeding of two carriers.
Publication Date: 2020-06-23 PubMed ID: 32463964PubMed Central: PMC7704864DOI: 10.1111/evj.13290Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores the impact of genetic bleeding disorders on horses’ health and athletic performance, explaining the mechanisms of diseases like haemophilia A, von Willebrand disease, and others. Genetic mutations linked to these disorders have been identified. The article also addresses the diagnosis and prevention measures for these disorders.

Overview of Genetic Bleeding Disorders in Horses

  • The paper begins by acknowledging the significance of understanding the genetic bleeding disorders in horses, emphasized due to their potential to drastically affect the horse’s health and career.
  • It specifically mentions various diseases, including haemophilia A, von Willebrand disease, prekallikrein deficiency, Glanzmann’s Thrombasthenia, and Atypical Equine Thrombasthenia which are associated with these disorders. Exercise-induced pulmonary haemorrhage is also mentioned, suggesting a possible genetic factor.

Genetic Mutations and Their Influence

  • The research identifies the existence of genetic mutations that are directly linked to haemophilia A and Glanzmann’s Thrombasthenia in horses.
  • The presence of mutations is also confirmed for von Willebrand disease and prekallikrein deficiency but in different species.

Diagnosis of Bleeding Disorders

  • The study talks about the diagnosis of these disorders in the absence of genetic tests. They are generally diagnosed by measuring certain aspects such as platelet function, levels of von Willebrand factor, and other coagulation protein levels and activities.

Prevention of Bleeding Disorders

  • For autosomal recessive diseases, the article argues that the application of genetic testing can be an effective prevention measure, as it can avoid the breeding of two carrier horses. This approach ensures that offspring do not inherit the undesirable traits, thus eliminating the possibility of the disorder being passed on to the next generation.

Cite This Article

APA
Dahlgren AR, Tablin F, Finno CJ. (2020). Genetics of equine bleeding disorders. Equine Vet J, 53(1), 30-37. https://doi.org/10.1111/evj.13290

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 53
Issue: 1
Pages: 30-37

Researcher Affiliations

Dahlgren, Anna R
  • Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA.
Tablin, Fern
  • Physiology and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA, USA.
Finno, Carrie J
  • Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA.

MeSH Terms

  • Animals
  • Blood Coagulation Disorders / genetics
  • Blood Coagulation Disorders / veterinary
  • Blood Coagulation Factors
  • Hemorrhage / veterinary
  • Hemostasis
  • Horse Diseases / genetics
  • Horses
  • Thrombasthenia / genetics
  • Thrombasthenia / veterinary

Grant Funding

  • L40 TR001136 / NCATS NIH HHS
  • Louis R. Rowan Fellowship, UC Davis Center for Equine Health
  • 5K01OD015134 / NIH HHS
  • LRP L40 TR001136 / NCATS NIH HHS
  • LRP L40 TR001136 / NIH HHS
  • K01 OD015134 / NIH HHS
  • Ann T. Bowling Fellowship, UC Davis Veterinary Genetics Laboratory
  • LRP L40 TR001136 / National Center for Advancing Translational Sciences

Conflict of Interest Statement

Authors’ declaration of interests. No competing interests have been declared.

References

This article includes 66 references
  1. Van Cott EM, Laposata M. Coagulation. In: Jacobs DS, Oxley DK, DeMott WR, editors. Lab. Test Handb 5th ed., Cleveland: Lexi-Comp; 2001, p. 327–58.
  2. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease.. Semin Immunopathol 2012 Jan;34(1):43-62.
    doi: 10.1007/s00281-011-0290-8pubmed: 22037947google scholar: lookup
  3. Mendez-Angulo JL, Mudge MC, Couto CG. Thromboelastography in equine medicine: Technique and use in clinical research. Equine Vet Educ 2012;24:639–49.
  4. Alcott C, Wong D, Brockus C, Sponseller B. Hemostasis. Compend Contin Educ Pract Vet (Equine Ed) 2009;4:78–89.
  5. Segura D, Monreal L. Poor reproducibility of template bleeding time in horses.. J Vet Intern Med 2008 Jan-Feb;22(1):238-41.
    doi: 10.1177/016555157900100507pubmed: 18289318google scholar: lookup
  6. Norton EM, Wooldridge AA, Stewart AJ, Cusimano L, Schwartz DD, Johnson CM, Boudreaux MK, Christopherson PW. Abnormal coagulation factor VIII transcript in a Tennessee Walking Horse colt with hemophilia A.. Vet Clin Pathol 2016 Mar;45(1):96-102.
    doi: 10.1111/vcp.12315pubmed: 26765501google scholar: lookup
  7. Littlewood JD, Bevan SA, Corke MJ. Haemophilia A (classic haemophilia, factor VIII deficiency) in a Thoroughbred colt foal.. Equine Vet J 1991 Jan;23(1):70-2.
  8. Hinton M, Jones DR, Lewis IM, Thomson PE. A clotting defect in an Arab colt foal.. Equine Vet J 1977 Jan;9(1):1-3.
  9. Hutchins DR, Lepherd EE, Crook IG. A case of equine haemophilia. Aust Vet J 1967;43:83–7.
  10. Archer RK, Allen BV. True haemophilia in horses.. Vet Rec 1972 Dec 23;91(26):655-6.
    pubmed: 4654307doi: 10.1136/vr.91.26.655google scholar: lookup
  11. NOSSEL HL, ARCHER RK, MACFARLANE RG. Equine haemophilia: report of a case and its response to multiple infusions of heterospecific AHG.. Br J Haematol 1962 Oct;8:335-42.
  12. Henninger RW. Hemophilia A in two related quarter horse colts.. J Am Vet Med Assoc 1988 Jul 1;193(1):91-4.
    pubmed: 3138224
  13. Feldman BF, Giacopuzzi RL. Hemophilia A (factor Vlll deficiency) in a colt. Equine Pract 1982;4:24–30.
  14. SANGER VL, MAIRS RE, TRAPP AL. HEMOPHILIA IN A FOAL.. J Am Vet Med Assoc 1964 Feb 1;144:259-64.
    pubmed: 14114821
  15. Archer RK. True haemophilia (haemophilia A) in a Thoroughbred foal. Vet Rec 1961;73:338–40.
  16. Mills JN, Bolton JR. Haemophilia A in a 3-year-old thoroughbred horse.. Aust Vet J 1983 Feb;60(2):63-4.
  17. AGGELER PM, WHITE SG, GLENDENING MB, PAGE EW, LEAKE TB, BATES G. Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.. Proc Soc Exp Biol Med 1952 Apr;79(4):692-4.
    pubmed: 14920537doi: 10.3181/00379727-79-19488google scholar: lookup
  18. ROSENTHAL RL, DRESKIN OH, ROSENTHAL N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.. Proc Soc Exp Biol Med 1953 Jan;82(1):171-4.
    pubmed: 13037836doi: 10.3181/00379727-82-20057google scholar: lookup
  19. Evans JP, Brinkhous KM, Brayer GD, Reisner HM, High KA. Canine hemophilia B resulting from a point mutation with unusual consequences.. Proc Natl Acad Sci U S A 1989 Dec;86(24):10095-9.
    doi: 10.1073/pnas.86.24.10095pmc: PMC298651pubmed: 2481310google scholar: lookup
  20. Mauser AE, Whitlark J, Whitney KM, Lothrop CD Jr. A deletion mutation causes hemophilia B in Lhasa Apso dogs.. Blood 1996 Nov 1;88(9):3451-5.
    pubmed: 8896410
  21. Brooks MB, Gu W, Ray K. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.. J Am Vet Med Assoc 1997 Dec 1;211(11):1418-21.
    pubmed: 9394892
  22. Gu W, Brooks M, Catalfamo J, Ray J, Ray K. Two distinct mutations cause severe hemophilia B in two unrelated canine pedigrees.. Thromb Haemost 1999 Oct;82(4):1270-5.
    pubmed: 10544912
  23. Brooks MB, Gu W, Barnas JL, Ray J, Ray K. A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs.. Mamm Genome 2003 Nov;14(11):788-95.
    doi: 10.1007/s00335-003-2290-zpubmed: 14722728google scholar: lookup
  24. Goree M, Catalfamo JL, Aber S, Boudreaux MK. Characterization of the mutations causing hemophilia B in 2 domestic cats.. J Vet Intern Med 2005 Mar-Apr;19(2):200-4.
  25. Centers for Disease Control and Prevention. CDC Hemophilia Mutation Project 2018. .
  26. Geor RJ, Jackson ML, Lewis KD, Fretz PB. Prekallikrein deficiency in a family of Belgian horses.. J Am Vet Med Assoc 1990 Sep 15;197(6):741-5.
    pubmed: 2211324
  27. Turrentine MA, Sculley PW, Green EM, Johnson GS. Prekallikrein deficiency in a family of miniature horses.. Am J Vet Res 1986 Nov;47(11):2464-7.
    pubmed: 3641551
  28. François D, Trigui N, Leterreux G, Flaujac C, Horellou MH, Mazaux L, Vignon D, Conard J, de Mazancourt P. Severe prekallikrein deficiencies due to homozygous C529Y mutations.. Blood Coagul Fibrinolysis 2007 Apr;18(3):283-6.
    pubmed: 17413767doi: 10.1097/mbc.0b013e328010bcdegoogle scholar: lookup
  29. Shigekiyo T, Fujino O, Kanagawa Y, Matsumoto T. Prekallikrein (PK) Tokushima: PK deficiency caused by a Gly401-->Glu mutation.. J Thromb Haemost 2003 Jun;1(6):1314-6.
  30. Lombardi AM, Sartori MT, Cabrio L, Fadin M, Zanon E, Girolami A. Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr).. Thromb Haemost 2003 Dec;90(6):1040-5.
    doi: 10.1160/TH03-05-0275pubmed: 14652634google scholar: lookup
  31. Wynne Jones D, Russell G, Allford SL, Burdon K, Hawkins GA, Bowden DW, Minaee S, Mumford AD. Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation.. Br J Haematol 2004 Oct;127(2):220-3.
  32. Okawa T, Yanase T, Shimokawa Miyama T, Hiraoka H, Baba K, Tani K, Okuda M, Mizuno T. Prekallikrein deficiency in a dog.. J Vet Med Sci 2011 Jan;73(1):107-11.
    pubmed: 20736516doi: 10.1292/jvms.10-0207google scholar: lookup
  33. Wuepper KD, Miller DR, Lacombe MJ. Flaujeac trait. Deficiency of human plasma kininogen.. J Clin Invest 1975 Dec;56(6):1663-72.
    pmc: PMC333145pubmed: 127805doi: 10.1172/jci108248google scholar: lookup
  34. Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry.. Semin Thromb Hemost 2002 Apr;28(2):227-38.
    pubmed: 11992245doi: 10.1055/s-2002-27824google scholar: lookup
  35. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE. Acquired von Willebrand syndrome: data from an international registry.. Thromb Haemost 2000 Aug;84(2):345-9.
    doi: 10.1055/s-0037-1614018pubmed: 10959711google scholar: lookup
  36. Dodds WJ. Von Willebrand's disease in dogs.. Mod Vet Pract 1984 Sep;65(9):681-6.
    pubmed: 6332976
  37. Turner NA, Moake JL, McIntire LV. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.. Blood 2001 Dec 1;98(12):3340-5.
    doi: 10.1182/blood.V98.12.3340pubmed: 11719372google scholar: lookup
  38. Mazzucato M, Cozzi MR, Pradella P, Ruggeri ZM, De Marco L. Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow.. Blood 2004 Nov 15;104(10):3221-7.
    doi: 10.1182/blood-2004-03-1145pubmed: 15284110google scholar: lookup
  39. Rathgeber RA, Brooks MB, Bain FT, Byars TD. Clinical vignette. Von Willebrand disease in a Thoroughbred mare and foal.. J Vet Intern Med 2001 Jan-Feb;15(1):63-6.
    doi: 10.1093/rheumatology/ket281pubmed: 11215915google scholar: lookup
  40. Laan TT, Goehring LS, Sloet van Oldruitenborgh-Oosterbaan MM. Von Willebrand's disease in an eight-day-old quarter horse foal.. Vet Rec 2005 Sep 10;157(11):322-4.
    doi: 10.1136/vr.157.11.322pubmed: 16155242google scholar: lookup
  41. Brooks M, Leith GS, Allen AK, Woods PR, Benson RE, Dodds WJ. Bleeding disorder (von Willebrand disease) in a quarter horse.. J Am Vet Med Assoc 1991 Jan 1;198(1):114-6.
    pubmed: 1995565
  42. de Jong A, Eikenboom J. Von Willebrand disease mutation spectrum and associated mutation mechanisms.. Thromb Res 2017 Nov;159:65-75.
  43. Venta PJ, Li J, Yuzbasiyan-Gurkan V, Brewer GJ, Schall WD. Mutation causing von Willebrand's disease in Scottish Terriers.. J Vet Intern Med 2000 Jan-Feb;14(1):10-9.
  44. Vos-Loohuis M, van Oost BA, Dangel C, Langbein-Detsch I, Leegwater PA. A novel VWF variant associated with type 2 von Willebrand disease in German Wirehaired Pointers and German Shorthaired Pointers.. Anim Genet 2017 Aug;48(4):493-496.
    doi: 10.1111/age.12544pubmed: 28696025google scholar: lookup
  45. Rieger M, Schwarz HP, Turecek PL, Dorner F, van Mourik JA, Mannhalter C. Identification of mutations in the canine von Willebrand factor gene associated with type III von Willebrand disease.. Thromb Haemost 1998 Aug;80(2):332-7.
    pubmed: 9716162
  46. Kramer JW, Venta PJ, Klein SR, Cao Y, Schall WD, Yuzbasiyan-Gurkan V. A von Willebrand's factor genomic nucleotide variant and polymerase chain reaction diagnostic test associated with inheritable type-2 von Willebrand's disease in a line of german shorthaired pointer dogs.. Vet Pathol 2004 May;41(3):221-8.
    pubmed: 15133170doi: 10.1354/vp.41-3-221google scholar: lookup
  47. Macieira S, Rivard GE, Champagne J, Lavoie JP, Bédard C. Glanzmann thrombasthenia in an Oldenbourg filly.. Vet Clin Pathol 2007 Jun;36(2):204-8.
  48. Christopherson PW, Insalaco TA, van Santen VL, Livesey L, Bourne C, Boudreaux MK. Characterization of the cDNA Encoding alphaIIb and beta3 in normal horses and two horses with Glanzmann thrombasthenia.. Vet Pathol 2006 Jan;43(1):78-82.
    doi: 10.1354/vp.43-1-78pubmed: 16407493google scholar: lookup
  49. Macieira S, Lussier J, Bédard C. Characterization of the cDNA and genomic DNA sequence encoding for the platelet integrin alpha IIB and beta III in a horse with Glanzmann thrombasthenia.. Can J Vet Res 2011 Jul;75(3):222-7.
    pmc: PMC3122970pubmed: 22210999
  50. Sanz MG, Wills TB, Christopherson P, Hines MT. Glanzmann thrombasthenia in a 17-year-old Peruvian Paso mare.. Vet Clin Pathol 2011 Mar;40(1):48-51.
  51. Christopherson PW, van Santen VL, Livesey L, Boudreaux MK. A 10-base-pair deletion in the gene encoding platelet glycoprotein IIb associated with Glanzmann thrombasthenia in a horse.. J Vet Intern Med 2007 Jan-Feb;21(1):196-8.
  52. Reichert N, Seligsohn U, Ramot B. Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases.. Thromb Diath Haemorrh 1975 Dec 15;34(3):806-20.
    pubmed: 1239828
  53. Norris JW, Pombo M, Shirley E, Blevins G, Tablin F. Association of Factor V Secretion with Protein Kinase B Signaling in Platelets from Horses with Atypical Equine Thrombasthenia.. J Vet Intern Med 2015 Sep-Oct;29(5):1387-94.
    doi: 10.1111/jvim.13595pmc: PMC4858037pubmed: 26290457google scholar: lookup
  54. Fry MM, Walker NJ, Blevins GM, Magdesian KG, Tablin F. Platelet function defect in a thoroughbred filly.. J Vet Intern Med 2005 May-Jun;19(3):359-62.
    doi: 10.1007/s11999-009-0725-xpubmed: 15954553google scholar: lookup
  55. Norris JW, Pratt SM, Auh JH, Wilson SJ, Clutter D, Magdesian KG, Ferraro GL, Tablin F. Investigation of a novel, heritable bleeding diathesis of Thoroughbred horses and development of a screening assay.. J Vet Intern Med 2006 Nov-Dec;20(6):1450-6.
  56. Norris JW, Pratt SM, Hunter JF, Gardner IA, Tablin F. Prevalence of reduced fibrinogen binding to platelets in a population of Thoroughbreds.. Am J Vet Res 2007 Jul;68(7):716-21.
    doi: 10.2460/ajvr.68.7.716pubmed: 17605606google scholar: lookup
  57. Weiss DJ, McClay CB, Smith CM, Rao GH, White JG. Platelet function in the racing thoroughbred: implication for exercise-induced pulmonary hemorrhage.. Vet Clin Pathol 1990;19(2):35-39.
  58. Johnstone IB, Viel L, Crane S, Whiting T. Hemostatic studies in racing standardbred horses with exercise-induced pulmonary hemorrhage. Hemostatic parameters at rest and after moderate exercise.. Can J Vet Res 1991 Apr;55(2):101-6.
    pmc: PMC1263427pubmed: 1909208
  59. Bayly WM, Meyers KM, Keck MT, Huston LJ, Grant BD. Effects of Exercise on the Hemostatic System of Thoroughbred Horses Displaying Post-Exercise Epistaxis. Equine Vet Sci 1983;3:191–3.
  60. Pascoe JR, Ferraro GL, Cannon JH, Arthur RM, Wheat JD. Exercise-induced pulmonary hemorrhage in racing thoroughbreds: a preliminary study.. Am J Vet Res 1981 May;42(5):703-7.
    pubmed: 7258791
  61. Raphel CF, Soma LR. Exercise-induced pulmonary hemorrhage in Thoroughbreds after racing and breezing.. Am J Vet Res 1982 Jul;43(7):1123-7.
    pubmed: 7103190
  62. Lapointe JM, Vrins A, McCarvill E. A survey of exercise-induced pulmonary haemorrhage in Q standardbred racehorses.. Equine Vet J 1994 Nov;26(6):482-5.
  63. Hillidge C, Lane T, Johnson E, Asquith R. Preliminary investrigations of exercised-induced pulmonary hemorrhage in racing quarter horses. Equine Vet Sci 1984;4:21–3.
  64. Weideman H, Schoeman SJ, Jordaan GF. A genetic analysis of epistaxis as associated with EIPH in the Southern African Thoroughbred. South African J Anim Sci 2004;34:265–73.
  65. Velie BD, Raadsma HW, Wade CM, Knight PK, Hamilton NA. Heritability of epistaxis in the Australian Thoroughbred racehorse population.. Vet J 2014 Nov;202(2):274-8.
    doi: 10.1016/j.tvjl.2014.06.010pubmed: 25011713google scholar: lookup
  66. Perez-Moreno CI, Couëtil LL, Pratt SM, Ochoa-Acuña HG, Raskin RE, Russell MA. Effect of furosemide and furosemide-carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses.. Can Vet J 2009 Aug;50(8):821-7.
    pmc: PMC2711466pubmed: 19881919

Citations

This article has been cited 1 times.
  1. Jamieson CA, Baillie SL, Johnson JP. Blood Transfusion in Equids-A Practical Approach and Review. Animals (Basel) 2022 Aug 23;12(17).
    doi: 10.3390/ani12172162pubmed: 36077883google scholar: lookup